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A B S T R A C T
The effect of Akpan (yoghurt-like product) consumption on the human intestinal microbiota
was examined. The prebiotic potential of Akpan was assessed by in vitro fermentation using,
as inocula, individual probiotic strains and faecal samples from three healthy donors. In
this latter case, the prebiotic activity was assessed through the quantification of short chain
fatty acid (SCFA) production, the evolution of the pH and the evaluation of dynamic bac-
terial population by fluorescent in situ hybridization (FISH). Results demonstrated that Akpan
was metabolized after 44 h of fermentation, exerting a prebiotic effect, similar to that ob-
served for fructooligosaccharides (FOS). All the considered bacterial groups significantly
increased after Akpan and FOS fermentation. Under the tested conditions, no significant
differences between the SCFA concentration produced by Akpan and FOS after of incuba-
tion were detected. Our findings contribute to support the utilization of Akpan as a functional
food with potential beneficial effects on gastrointestinal health.








Fermented cereal foods are widely consumed worldwide, es-
pecially in many African countries, where they are valued due
to their taste, aroma, bioactive constituents, and texture (Franz
et al., 2014; Sacca et al., 2012). These foods generally contain
health-promoting compounds beyond traditional nutrients as
they are considered to have some health benefits, and to aid
in the control of some diseases, in particular intestinal
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disorders (Franz et al., 2014; Mathara, Schillinger, Kutima,
Mbugua, & Holzapfel, 2004).
Ogi is a starchy product obtained by fermentation of a sus-
pension of wet-milled cereal (commonly maize, although
sorghum or millet is also employed as raw material) (Akissoé
et al., 2014; Nago, Hounhouigan, Akissoé, Zanou, & Mestres,
1998). It is considered the most important weaning food for
infants in West Africa, although it is also consumed by adults
(Blandino, Al-Aseeri, Pandiella, Canterob, & Webb, 2003). Ogi
is used for Akpan preparation, a traditional yoghurt-like product
made from fermented cereal starch, and consumed as a thirst-
quenching beverage in Benin (Akissoé et al., 2014). Like many
other indigenous fermented cereal products, Akpan is appre-
ciated for its sweet but slightly sour taste and the aroma of
its active components, which are developed naturally during
processing or are added during consumption (Akissoé et al.,
2014; Sacca et al., 2012). Akpan is of great economic signifi-
cance in urban and rural areas in Benin and it will take on
increasing importance in the future due to the many vari-
ants currently available. Indeed, the consumer demand for non-
dairy products such as Akpan (commonly known as “vegetal
yoghurt”) is a challenge for the food industry in the future (Sacca
et al., 2012).
Research studies on Akpan are very limited and focused
towards its basic description, as well as to its sensory quality
and nutritional attributes (Akissoé et al., 2014). However, to the
best of our knowledge, other properties such as the impact of
Akpan on human intestinal microbiota have not yet been in-
vestigated. Therefore, taking into account that the diet is
considered a major driver for changes in gut bacterial diver-
sity that can affect its functional relationships with the host,
it seems interesting to assess how this product can affect the
intestinal microbial ecosystem (Laparra & Sanz, 2010; Maccaferri
et al., 2012). In this context, Maccaferri et al. (2012) demon-
strated the ability of different flours (whole grain rye, whole
grain wheat, chickpeas and lentils 50:50, and barley milled
grains) to modulate the intestinal microbiota composition.
The aim of this work was to evaluate the impact of Akpan
on gut microbiota using small-scale in vitro batch culture. The
prebiotic potential of this product was assessed by measur-
ing the dynamics of selected microbial populations using the
fluorescent in situ hybridization (FISH) technique. The produc-
tion of short-chain fatty acids (SCFAs) and the pH evolution
were also determined in this work. The assessment of Akpan
as fermentable substrate for probiotic bacteria and its influ-
ence on their growth and metabolic activity were also studied.
The final objective of this study was to contribute to the de-
velopment of novel marketable functional foods, which can be
included in dietary strategies for human health promotion.
2. Materials and methods
2.1. Raw materials and Akpan preparation
Akpan was prepared in the Cirad laboratory using white maize
grains provided by Abomey-Calavi University (Cotonou, Benin)
as raw material.The traditional process for making Akpan from
white maize ogi was described by Sacca et al. (2012). It in-
volves the following steps: i) the grains were steeped in boiling
water for 5 min and left in water for 24 h until it reached room
temperature (grain/water ratio: 1/2), ii) the steeped grains were
milled using a grinder (Thermomix Vorwerk; for 1.5 min, de-
pending on the amount) and iii) the wet maize meal was sifted
through a 315 µm sieve using a large amount of water (wet flour/
water ratio: 1/3) for separating flour and bran. Then, the slurry
collected under the sieve was transferred to a crystallizer and
a lactic acid starter (Lactobacillus casei CNCM I-4592, Lesaffre
Company, Marcq-en-Baroeul, France) was added. Finally, the
mixture was fermented for 20–24 h in an oven at 35 °C. The
starter was previously activated at 35 °C for 5–7 h in a small
amount of maize flour slurry obtained as described above. The
supernatant of the fermented product was separated. Part of
it (85%) was boiled; the other part (15%) was remixed with the
fermented flour (ogi).The boiled supernatant was added to part
of the ogi (70%), which was cooked for 15 min at a tempera-
ture of 80–90 °C. The 30% of raw ogi put aside was added to the
cooked ogi after cooling and thus, Akpan, a partially cooked
product, was obtained. The Akpan was then freeze dried and
stored at refrigeration temperature to perform microbiologi-
cal studies.
2.2. In vitro digestion of Akpan
In vitro digestion of Akpan consisted of a simulated gastric di-
gestion, followed by a small intestinal digestion, as described
by Mills et al. (2008), with some modifications. Briefly, 8 g of
freeze-dried sample was mixed with water (30 mL) and the
mixture was homogeneized for 2 min. The solution was then
transferred to an Erlenmeyer flask, and the mouth phase was
initiated by adding α-amylase (2.6 mg in 2.5 mL of 1 mM CaCl2
solution; pH 7.0) and incubated at 37 °C for 30 min. At the end
of the incubation period, the pH value was decreased to 2 by
adding 6 M HCl. Then pepsin (0.36 g in 0.625 mL of 0.1 M HCl)
was added to the mixture and incubated for 2 h under the same
conditions mentioned above. Subsequently, the pH was in-
creased to 7.0 by addition of 6 M NaOH, and pancreatin (0.075 g)
and bovine bile salts (0.468 g) dissolved in 3.2 mL of 0.5 M
NaHCO3 were added to start the small intestinal phase. The
resulting slurry was then transferred to a 1 kDa molecular
weight cut-off (MWCO) dialysis tubing and dialysed for 2 d at
20 °C in order to remove low molecular mass digestion prod-
ucts. Finally, the resulting sample was freeze-dried and stored
for fermentation experiments.
2.3. Evaluation of Akpan as a source of fermentable
carbohydrates for probiotic bacteria growth
2.3.1. Microorganisms and growth conditions
Four bacterial strains were used in this study: L. casei L431 and
Bifidobacterium lactis B94 (from DELVO PRO LAFTI; DSM, Heerlen,
The Netherlands) and L. casei L01 and Bifidobacterium animalis
Bb12 (from Chr. Hansen; Hørsholm, Denmark). Strains were
stored at −80 °C in de Man–Rogosa–Sharpe (MRS) broth (Biokar
Diagnostics, Beauvais, France) with 30% (v/v) glycerol. Before
the assays, all strains were grown in MRS broth at 37 °C for 16 h.
Anaerobic conditions were used for B. lactis B94 and B. animalis
Bb12, whereas aerobic atmosphere was used for lactobacilli
strains. All tested strains are considered as probiotics as
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previously reported in different studies (Hernandez-Hernandez
et al., 2012; Rodrigues et al., 2011). Fermentation assays were
carried out for each strain in media containing: MRS-medium
supplemented with 1% (w/v) of Akpan, 1% (w/v) fructooli-
gosaccharides (FOS, used as reference) and MRS medium
without carbon source at 37 °C for 48 h.
2.3.2. In vitro fermentation assays
The composition of the de Man, Rogosa, and Sharpe (MRS) basal
media (pH 6.8) employed in this study was as follows: 10 g/L
of protease peptone, 10 g/L of beef extract, 5 g/L of yeast extract,
1 g/L of Tween 80, 2 g/L of ammonium citrate, 5 g/L of sodium
acetate, 0.1 g/L of magnesium sulphate, 0.05 g/L of manga-
nese sulphate, 2 g/L of dipotassium sulphate, 0.05 g/L of cysteine
hydrochloride (before inoculation in the case of anaerobic
strain), and 1% (w/v) of Akpan or FOS. FOS was used as posi-
tive control due to its well-established prebiotic properties,
whereas MRS without any carbon source was used as nega-
tive control.The media were sterilized at 110 °C for 20 min, and
the incubation was carried out at 37 °C using an inoculum made
up of Lactobacillus or Bifidobacterium cells (grown on MRS broth
media for 16 h). All fermentations were started with ca. 106 CFU/
mL. Samples of the fermentation broths were withdrawn at
0, 5, 10, 24 and 48 h for metabolite analysis and cell counting.
Viable cells were quantified by plating on MRS agar
(supplemented with cysteine hydrochloride in the case of
Bifidobacterium) and incubation at 37 °C for 48 h (anaerobic and
aerobic conditions were used for Bifidobacterium and Lactoba-
cilli strains, respectively). All experiments were carried out in
duplicate. Metabolite production was determined by HPLC using
the method described in section 2.4.4.
2.4. Prebiotic effect
2.4.1. Faecal samples and in vitro fermentations
Faecal samples were obtained from healthy human donors
(three females; age 25–35 years old), who ingested a normal
diet, without any known metabolic or gastrointestinal disor-
ders and had not taken antibiotics 3 months prior to faecal
sample donation. Faeces were collected and kept in an an-
aerobic cabinet (Model Bactron IV, Shel-Lab, Cornelius, OR, USA)
for a maximun of 2 h after collection. The faecal inocula (FI)
were prepared as per Gullón et al. (2014).
Samples of Akpan were assayed for their in vitro
fermentability according the method of Gullón et al. (2014). Fer-
mentations were run over a period of 44 h, and 3 mL samples
were taken at 0, 6, 24 and 44 h to be analysed for their bacte-
rial populations by fluorescent in situ hybridization (FISH). The
pH of the medium was also measured and lactic acid and short
chain fatty acids (SCFAs) were quantified by HPLC. All addi-
tions and inoculations were carried out inside an anaerobic
cabinet (5% H2, 10% CO2 and 85% N2).
2.4.2. Bacterial enumeration by fluorescent in situ
hybridization (FISH) assays
FISH was performed as previously described (Gullón, Gullón,
Sanz, Alonso, & Parajó, 2011). Synthetic oligonucleotide probes
(TIB MOLBIOL, S.L., Spain) targeting specific regions of the 16S
rRNA molecule and labelled with the fluorescent dye Cy3
(Sigma) were utilized for the enumeration of bacterial groups:
Bif164, specific for the Bifidobacterium genus; Lab158, for the
Lactobacillus–Enterococcus group; Bac303, specific for the
Bacteroides–Prevotella group; His150, for the Clostridium histolyticum
subgroup; Erec482 for the Ruminococcus–Eubacterium–Clostridium
cluster and Fpra655 for Faecalibacterium prausnitzii and rela-
tives. Total cell counts were performed by staining with 4′,6-
diamidino-2-phenylindole (DAPI). Cells were counted using an
epifluorescence microscope (Olympus BX41). A minimum of 10
fields were counted per sample analysed.
2.4.3. Fermentation metabolites analyses
Supernatants from the fermentation media were filtered
through 0.20 µm cellulose acetate membranes. Aliquots of the
filtered samples were assayed for organic acids (succinic, lactic,
formic, acetic, propionic and butyric acids) using an Agilent 1200
series HPLC instrument with a refractive index (RI) detector
(Agilent, Waldbronn, Germany) operated at 50 °C. Other analy-
sis conditions were as follows: Aminex HPX-87H column (from
BioRad, Hercules, CA, USA); mobile phase, 0.003 M H2SO4; flow,
0.6 mL/min.
2.5. Statistical analysis
Statistical analysis was performed using SPSS for Windows
version 21.0 (IBM SPSS, Chicago, IL). Univariate analysis of vari-
ance (ANOVA) and the post hoc Tukey test were used to
determine the significance of the effect of Akpan on bacte-
rial group populations and SCFA production. Differences were
considered significant at the 5% level.
3. Results and discussion
3.1. Effects of Akpan on the probiotic growth
In order to assess the suitability of Akpan as a fermentable car-
bohydrate source for probiotic bacteria, in vitro fermentation
assays were carried out using two Lactobacillus strains (L. casei
L431 and L. casei L01) and two Bifidobacterium strains (B. animalis
Bb12 and B. lactis B94). Fig. 1 shows the time course of the
number of viable cells (expressed as log CFU/mL) for the dif-
ferent strains tested as well as pH evolution in the fermentation
media. As expected, a very limited growth was observed in the
negative control assay confirming that the growth enhance-
ment was a consequence of the carbohydrates added (Akpan
and FOS).
Regarding the Bifidobacteria strains, a stimulatory effect on
the growth was observed after 48 h using both Akpan and FOS.
The viable cell numbers of B. animalis reached a value of
8.07 log CFU/mL (as average) for both fermentable carbohy-
drate sources. However, some differences were observed in the
case of B. lactis B94; the number of viable cells at the end of
fermentation was slightly higher in media containing FOS
(8.75 log CFU/mL and 8.24 log CFU/mL for FOS and Akpan, re-
spectively).The pH showed a similar trend for both carbohydrate
sources, when the medium was inoculated with B. animalis Bb12
(Fig. 1). By contrast, when B. lactis B94 was cultured in media
containing FOS, a higher reduction in pH was observed in
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comparison with Akpan (final pH = 4.2 and 5.2 for FOS and
Akpan, respectively).These results are in agreement with those
obtained for the viable cell numbers (B. lactis B94 reached higher
values in media containing FOS).
Regarding L. casei L431 and L. casei L01, no growth enhance-
ment was observed for Akpan (Fig. 1), showing similar profiles
to the one observed in the negative control. However, the de-
crease in pH values was similar for both Akpan and FOS,
containing cells of L. casei L01. After 48 h of fermentation, pH
values of 6 and 6.3 were reached in media containing Akpan
and FOS, respectively. In the case of L. casei L431, the pH de-
creased to 4 for media containing FOS after 48 h. When this
strain was cultured in media containing Akpan, the pH re-
mained almost constant.
HPLC analysis confirmed the presence of lactate, formate
and acetate as fermentation products in the cell-free culture
supernatants. However, variations in the production of these
acids for the various strains and substrates were observed
(Table 1). In general, strains L. casei L431 and B. lactis B94 grown
in media containing FOS produced higher lactic acid concen-
trations than those achieved when Akpan is used as substrate.
Acetic acid levels were higher in media containing Akpan in
comparison with FOS for both L. casei L431 and B. lactis B94.
Cultures of strains L. casei L01 and B. animalis Bb12 produced
similar amounts of lactic and formic acids, regardless of the
substrates used as fermentable carbohydrates. However, these
strains produced a higher amount of acetic acid in the media
containing Akpan.
Recently, Tadayoni, Sheikh-Zeinoddin, and Soleimanian-Zad
(2015) observed that Lactobacillus plantarum A7 can metabo-
lize polysaccharides from acorn.The effectiveness of a prebiotic
carbohydrate depends on its ability to be selectively fer-
mented by specific targeted organisms. This is in agreement
with a number of studies that demonstrate that the ability of
lactobacilli and bifidobacteria to ferment prebiotic carbohy-
drates depends on the strain and substrate tested (Huebner,
Wehling, & Hutkins, 2007).
Akpan is obtained from fermented cereal, and contains sig-
nificant amounts of polysaccharides that act as fermentable
carbohydrates for supporting the growth of Lactobacillus and
Bifidobacterium strains, resulting in the production of organic
acids.
3.2. Effects of Akpan on the intestinal microbiota
3.2.1. Changes in bacterial populations during in vitro batch
culture fermentation
In this work, in vitro modification of the faecal microbiota by
Akpan and FOS was monitored by FISH. The data shown in










































































































































































Fig. 1 – Viable cell numbers (log CFU/mL) (___) of Lactobacillus casei L431, Lactobacillus casei L01, Bifidobacterium animalis Bb12
and Bifidobacterium lactis B94 and pH (—) values throughout incubation time (48 h) at 37 °C growing in MRS-medium
supplemented with 1% (w/v) of Akpan (■), 1% (w/v) FOS (▲) and MRS medium without fermentable carbohydrates (●).
Values are expressed as the mean ± standard deviation (SD) of independent duplicate assays.
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increased significantly with time in experiments containing FOS
and Akpan. On the contrary, in negative control cultures, no
variations were observed in the bacterial growth. In media con-
taining FOS and Akpan, the total cell counts increased (as
average) up to 17% at 44 h (this value did not show signifi-
cant differences (p > 0.05) for both Akpan and FOS).
Regarding Bifidobacterium population, the data confirmed a
preferential growth of this genus when FOS or Akpan was used
Table 1 – Organic acids concentrations (mM) along the fermentation using Akpan or FOS as substrates in media




Acid Time (h) L431 L01 Bb12 B94
Akpan Lactic 5 4.67 ± 0.15 4.86 ± 0.42 2.32 ± 0.21 1.15 ± 0.27
10 11.26 ± 0.24 5.88 ± 0.89 2.17 ± 0.74 1.24 ± 0.34
24 7.96 ± 1.78 6.58 ± 1.25 0.97 ± 0.12 9.09 ± 1.21
48 9.07 ± 2.31 6.89 ± 1.33 0.45 ± 0.24 9.45 ± 1.56
Formic 5 2.26 ± 0.45 1.72 ± 0.48 1.16 ± 0.21 0.00 ± 0.00
10 5.45 ± 1.23 0.00 ± 0.00 6.71 ± 1.55 3.28 ± 1.21
24 5.19 ± 0.75 0.00 ± 0.00 7.42 ± 0.33 7.02 ± 0.75
48 0.00 ± 0.00 0.00 ± 0.00 3.95 ± 1.80 0.00 ± 0.00
Acetic 5 6.30 ± 1.25 5.90 ± 1.34 7.45 ± 2.34 9.97 ± 1.27
10 16.23 ± 3.24 12.81 ± 3.12 13.47 ± 3.47 13.34 ± 2.87
24 18.72 ± 4.21 23.78 ± 5.25 11.86 ± 2.41 17.79 ± 3.24
48 19.81 ± 1.34 24.43 ± 4.85 13.23 ± 1.29 19.24 ± 3.78
FOS Lactic 5 5.90 ± 1.27 6.39 ± 0.78 2.22 ± 0.37 16.62 ± 2.24
10 59.09 ± 12.45 7.32 ± 0.36 0.00 ± 0.00 31.52 ± 4.34
24 110.42 ± 14.45 7.05 ± 1.21 0.00 ± 0.00 47.97 ± 8.12
48 109.13 ± 7.25 9.54 ± 1.78 0.00 ± 0.00 92.50 ± 7.45
Formic 5 1.59 ± 0.23 1.05 ± 0.10 4.66 ± 10.35 3.39 ± 0.21
10 0.00 ± 0.00 5.93 ± 1.00 7.30 ± 0.78 7.56 ± 1.27
24 0.00 ± 0.00 2.13 ± 0.17 7.09 ± 1.98 0.00 ± 0.00
48 0.00 ± 0.00 0.00 ± 0.00 5.88 ± 0.74 0.00 ± 0.00
Acetic 5 3.69 ± 1.25 4.44 ± 0.38 5.34 ± 1.00 9.56 ± 2.48
10 5.00 ± 1.64 9.29 ± 1.25 5.44 ± 0.87 10.91 ± 1.39
24 3.79 ± 0.87 15.05 ± 2.38 5.53 ± 1.21 13.22 ± 0.15
48 9.31 ± 1.21 19.03 ± 3.45 6.99 ± 1.11 17.10 ± 1.72
Lactic 5 5.26 ± 0.64 3.80 ± 0.11 0.00 ± 0.00 0.30 ± 0.02
10 5.21 ± 0.13 3.53 ± 0.10 0.00 ± 0.00 0.97 ± 0.01
24 4.11 ± 0.42 2.55 ± 0.16 0.00 ± 0.00 1.41 ± 0.14
48 4.66 ± 0.23 2.88 ± 0.17 0.00 ± 0.00 1.14 ± 0.29
Formic 5 5.15 ± 0.31 2.26 ± 0.29 0.69 ± 0.11 2.64 ± 0.37
10 3.91 ± 0.10 7.57 ± 0.42 7.56 ± 0.79 6.83 ± 1.15
24 0.00 ± 0.00 3.56 ± 0.32 4.53 ± 0.25 5.47 ± 0.55
48 0.00 ± 0.00 0.00 ± 0.00 6.11 ± 1.19 5.67 ± 0.39
Acetic 5 5.25 ± 0.91 7.28 ± 0.55 0.00 ± 0.00 0.00 ± 0.00
10 6.90 ± 0.74 9.16 ± 0.98 2.50 ± 0.12 4.25 ± 0.21
24 8.99 ± 0.39 9.16 ± 1.12 2.33 ± 0.09 5.33 ± 0.33
48 9.66 ± 1.12 6.83 ± 0.33 5.38 ± 0.28 0.00 ± 0.00
Values are expressed as mean ± standard deviation (SD) of two replicates.
Table 2 – Changes in bacteria population (expressed as log cells/mL) after 0, 6, 24 and 44 h in vitro fermentation of FOS,
Akpan and negative control.
Group FOS Akpan Negative control
0 h 6 h 24 44 h 6 h 24 44 h 6 h 24 44 h
DAPI 8.13 ± 0.04 9.04b ± 0.36 9.87b ± 0.23 9.66b ± 0.31 9.13b ± 0.05 9.61b ± 0.05 9.89b ± 0.21 8.50a ± 0.03 8.52a ± 0.12 8.37a ± 0.02
Bif164 7.46 ± 0.11 8.43b ± 0.34 8.67b ± 0.04 8.65b ± 0.14 8.45b ± 0.05 8.89c ± 0.06 8.86b ± 0.06 7.90a ± 0.05 7.71a ± 0.06 7.64a ± 0.14
Lab158 7.01 ± 0.10 8.66b ± 0.17 8.58b ± 0.16 8.47b ± 0.12 8.51b ± 0.04 8.93c ± 0.05 8.96c ± 0.15 7.87a ± 0.11 7.69a ± 0.06 7.40a ± 0.13
Chis150 7.49 ± 0.13 8.89c ± 0.14 8.83b ± 0.10 8.81b ± 0.23 8.64b ± 0.03 9.00b ± 0.08 8.91b ± 0.15 8.10a ± 0.05 7.92a ± 0.05 7.83a ± 0.12
Bac303 7.88 ± 0.01 8.83b ± 0.11 8.96b ± 0.08 8.93b ± 0.18 8.71b ± 0.07 8.93b ± 0.02 8.83b ± 0.09 8.08a ± 0.11 7.90a ± 0.13 7.84a ± 0.20
Erec482 7.51 ± 0.03 8.78b ± 0.21 9.00c ± 0.07 8.84b ± 0.20 8.46b ± 0.09 8.82b ± 0.08 8.76b ± 0.08 8.04a ± 0.05 7.74a ± 0.05 7.68a ± 0.06
Frap655 7.50 ± 0.14 8.60b ± 0.23 8.78b ± 0.04 8.62b ± 0.07 8.81b ± 0.08 9.00c ± 0.04 8.87c ± 0.07 7.92a ± 0.06 7.99a ± 0.07 7.86a ± 0.05
Total bacterial counts were obtained using DAPI and bacterial groups with FISH probes. Mean values ± SD (n = 3). Different letters indicate sig-
nificant differences (P ≤ 0.05) for each bacterial group. Substrates were compared at three fermentation sampling times (6, 24 and 44 h).
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as substrate in comparison with the negative control. Signifi-
cant growth (p ≤ 0.05) was observed in the number of
bifidobacteria at 24 h when Akpan was employed. After 44 h,
this number increased by 14 and 17% in experiments contain-
ing FOS and Akpan, respectively. FOS has previously been
reported to enhance the growth of bifidobacteria (Rivas, Gullón,
Gullón, Alonso, & Parajó, 2012; Rossi et al., 2005), but the
bifidogenic activity of Akpan is new in the scientific litera-
ture and these results show the bifidogenic effect of this
functional beverage. The results obtained in this work
are in agreement with the data published with similar sub-
strates. Costabile et al. (2008) reported an increased
number of faecal bifidobacteria after ingestion of the whole-
grain wheat breakfast cereal. Similarly, an increase in
bifidobacteria levels was also found during the fermentation
of arabinoxylooligosaccharides from wheat bran (Gullón et al.,
2014).
The Lactobacillus–Enterococcus group population was also
quantified in this work. A higher increase during incubation
with FOS and Akpan was observed with respect to the control
negative. In experiments containing Akpan, the levels of
Lactobacillus–Enterococcus increased significantly after 24 and 44 h
of incubation in comparison with the results obtained with FOS
(p ≤ 0.05). At 24 h of fermentation, the Lactobacillus counts in-
creased by 17 and 22% in cultures containing FOS and Akpan,
respectively. The differences observed in the fermentation of
Akpan using faecal inoculum were not in agreement with the
results obtained in pure cultures with Lactobacillus cells where
a low growth was observed. This fact can be explained on the
basis of a variety of different species that are present in faecal
inocula, enabling the complete fermentation of carbohy-
drates (Pastell, Westermann, Meyer, Tuomainen, & Tenkanen,
2009). In many cases, the metabolic end products generated
by some species can be used as substrates by other microor-
ganisms that cannot metabolize the original substrate (Gibson
& Roberfroid, 1995). This is the first evidence that shows the
stimulatory effect on intestinal lactobacilli populations with
Akpan.
Regarding C. histolyticum group Clusters I and II, the data
show that growth of this group was statistically significant in
cultures with FOS during the first 6 h of fermentation (see
Table 2). On the other hand, after 24 and 44 h of incubation,
no significant differences were observed between FOS and
Akpan. In a related study, Salazar et al. (2009) reported an in-
crease of this type of bacteria after 10 h using inulin as
fermentable carbohydrate, whereas Sarbini et al. (2011) did not
observe a significant increase of these clusters when fer-
mented dextrans were used. From the point of view of the
health effects, clostridia are mainly considered as harmful
bacteria.
Bacteroides–Prevotella is one of the predominant bacterial
group in gut microbiota, and it is a metabolically versatile group
as it can use many types of polysaccharides and produce acetic
acid and propionic acid (Salazar et al., 2009). As expected, FOS
and Akpan promoted the growth of Bacteroides–Prevotella in
faecal cultures, although no significant differences were ob-
served among both fermentable carbohydrates (see Table 2).
The Clostridium coccoides–Eubacterium rectale group and
F. prausnitzii play a physiological role related to their ability to
produce relatively large amounts of butyrate, which has been
shown to exert beneficial effects on gut health (Scott, Martin,
Duncan, & Flint, 2014). Regarding C. coccoides–E. rectale, gradual
increases in counts were observed during fermentations in cul-
tures with FOS and Akpan. After 44 h of fermentation, the
numbers increased (by an average) by 15% in cultures con-
taining FOS or Akpan. For instance, Kleessen, Hartmann, and
Blaut (2001) reported increased levels of C. coccoides–E. rectale
in a human-flora-associated (HFA) animal study after inges-
tion of inulin.
A significant increase in F. prausnitzii was also detected for
both substrates, although these changes are slightly more no-
ticeable for Akpan. After 24 h, the number of bacteria belonging
to this group increased (by an average) by 14%. Similar results
were observed using commercial prebiotics. For instance, Dewulf
et al. (2013) demonstrated that the dietary supplementation
with a mixed scFOS/inulin prebiotic stimulated numbers of
F. prausnitzii. Davis, Martínez, Walter, Goin, and Hutkins (2011)
also observed an increase in the number of F. prausnitzii after
galactooligosaccharides intake. The fact that Akpan stimu-
lated the growth of F. prausnitzii is important because this group
can be used as an indicator of intestinal health. In this context,
the modulation of F. prausnitzii abundance (for example, by using
functional ingredients such as prebiotics and/or probiotics)
might have therapeutic applications in human health (Miquel
et al., 2013).
3.2.2. Changes in lactic acid and short chain fatty acid profile
in faecal cultures
Table 3 summarizes the changes in SCFA and lactate concen-
trations along the fermentation of media containing Akpan or
FOS, as well as the pH variations. The samples were analysed
at 0, 6, 24 and 44 h. As can be expected, the increase in
total SCFAs and lactate was higher in the media containing
Akpan or FOS than in faecal cultures lacking fermentable
carbohydrates.
As can be seen, both Akpan as FOS were metabolized, leading
to a reduction of the pH values. These decreases were more
pronounced than the ones observed in control cultures, in which
the pH variation was mainly ascribed to the SCFA generation
from protein by putrefactive bacteria present in the intesti-
nal microbiota (Conlon & Bird, 2015; Hartemink, Schoustra, &
Rombouts, 1999).The highest concentrations in total SCFA were
detected after 44 h of fermentation for media containing FOS
and Akpan, although no significant differences were found
between both fermentable carbohydrates (see Table 3).
Succinic and formic acid (two intermediary products mainly
produced by bifidobacteria) were also quantified. Scarce pro-
duction of succinic acid was observed at short fermentation
times (data not shown). Regarding the formic acid, a substan-
tial increase was observed during the period 0–24 h, although
no significant differences were detected between FOS and
Akpan. The highest concentrations for formic acid (23.59 mM
from FOS and 20.27 mM from Akpan) were achieved after 24 h.
On the other hand, lactic acid (a typical metabolic product
of bifidobacteria and lactic bacteria) was also determined, being
more abundant in the experiments containing FOS. No lactic
acid was observed after 24 h of fermentation in any assay,
because it can be utilized by other intestinal bacteria as a carbon
source for producing acetate, propionate, and/or butyrate, sug-
gesting a cross-feeding mechanism (Belenguer et al., 2006). As
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expected, no lactic acid was detected in the negative control
experiment.
Acetate is the main SCFA in the gut, and it was the most
abundant SCFA in the fermentation media in this work. FOS
fermentation resulted in significantly higher amounts at 24 h
compared to Akpan (p ≤ 0.05). The highest concentrations were
achieved after 44 h (47.49 mM and 44.46 mM from FOS and
Akpan, respectively). As Bifidobacterium are acetic acid produc-
ers (Gullón et al., 2014; Schiffrin & Blum, 2002), the increase
of acetic acid during fermentation correlated well with the in-
crease in the populations of Bifidobacterium for both Akpan and
FOS (see Table 2). The predominant formation of acetic acid
is in line with the results reported by Connolly, Tuohy, and
Lovegrove (2012), when were fermented whole grain oat-
based cereals using faecal inocula.
Regarding propionic acid concentration, the highest amounts
of this acid were found in the experiments containing Akpan
(32.13 mM after 44 h), showing significant differences (ca. 3
times) (p ≤ 0.05) when compared to FOS at 24 and 44 h. This
positive modulation was also found during the fermentation
of other carbohydrate sources such as arabinoxylooligo-
saccharides from wheat bran (Gullón et al., 2014) and
arabinoxylans from brewer’s spent grain (Reis et al., 2014).
It should be noted that propionate is a gluconeogenerator,
which has been shown to inhibit biosynthesis of cholesterol
and fatty acids in liver. Therefore, carbohydrates that can de-
crease the acetate : propionate ratio may reduce serum lipids
and possibly cardiovascular disease risk (Delzenne & Kok, 2001;
Wong, de Souza, Kendall, Emam, & Jenkins, 2006). In this work,
the values for acetic acid/propionic acid ratio at 44 h were 1.38
for Akpan and 4.25 for FOS.The result obtained for Akpan com-
pared favourably with those achieved with other substrates in
related studies. Gómez et al. (2014) carried out a similar study
using pectin from orange peel wastes resulting in an acetic acid/
propionic acid ratio of 3.88 at 48 h. Reis et al. (2014) reported
average values of 2.5 at 48 h using arabinoxylans. These results
confirm that Akpan could be a promising alternative for re-
ducing serum lipids, since very low acetate/propionate ratios
were obtained if they are compared to other potential or com-
mercial prebiotics.
Butyrate has an important role as a carbon source for the
colonic mucosa, and it is considered a healthy metabolite, since
it positively influences cell growth and differentiation, exerts
anti-inflammatory effects and has been linked to a reduced
incidence of colon cancer (Laparra & Sanz, 2010; Wong et al.,
2006). The butyrate production in media containing FOS was
more pronounced than in cultures with Akpan, showing sig-
nificant differences (p ≤ 0.05). This result can be related to the
higher content of lactic acid during the period of 6–24 h for cul-
tures containing FOS, and, by a cross-feeding mechanism, this
acid can be converted into butyrate by common intestinal
microbiota (Russell, Hoyles, Flint, & Dumas, 2013). The highest
butyrate concentration for FOS was achieved after 44 h
(23.78 mM), whereas the media containing Akpan showed a sig-
nificantly lower concentration (5.23 mM). Similarly, Connolly
et al. (2012) also observed moderate increases in butyrate levels
in media containing different processed breakfast cereals.
Higher amounts of butyrate were also obtained for FOS in com-
parison with AOS in previously reported studies (Gullón et al.,
2014; Reis et al., 2014).
4. Conclusions
This work is the first study that shows the effects of Akpan
on the complex faecal human microbiota. The results ob-
tained here demonstrated that Akpan can be considered to exert
potential prebiotic effects, since it promotes the growth of ben-
eficial colonic bacterial populations and the production of SCFA.
Akpan can stimulate the growth of certain bacterial groups in
the human intestinal microbiota in an extent comparable to
FOS. Moreover, the fermentation of Akpan and FOS resulted
in similar SCFA productions, although the SCFA profile was dif-
ferent; Akpan fermentation resulted in a remarkable generation
of propionate, while FOS fermentation led to higher concen-
trations of butyrate. Therefore, the results of this work could
support that the consumption of this cereal-based fermented
beverage could improve the gut health.
Table 3 – Concentration (mM) of SCFA (acetate, propionate and butyrate), lactate and formate, and pH variation during in
vitro fermentation of Akpan, FOS and negative control at 6, 24, and 44 h.
Fermentable
carbohydrate
Time (h) pH Lactate Formate Acetate Propionate Butyrate Total SCFA
Akpan 0 7.2 0.14 ± 0.07 0.34 ± 0.15 1.28 ± 0.45 0.05 ± 0.00 0.24 ± 0.13 2.05 ± 0.19
6 6.5 1.03b ± 0.06 4.34b ± 2.45 5.57a ± 1.03 2.93b ± 0.63 0.00a ± 0.00 8.51a ± 0.58
24 5.8 2.57a ± 0.62 20.27b ± 4.26 32.86b ± 3.47 26.37b ± 4.80 1.75a ± 1.27 60.99b ± 9.51
44 5 0.00a ± 0.00 16.71b ± 5.16 44.46b ± 3.43 32.13b ± 6.46 5.23a ± 0.31 81.83b ± 10.05
FOS 0 7.2 0.18 ± 0.10 0.45 ± 0.12 2.75 ± 0.89 0.38 ± 0.16 0.45 ± 0.11 4.21 ± 0.25
6 6.0 2.60c ± 0.68 5.77b ± 0.74 13.34b ± 4.35 3.15b ± 1.05 1.04b ± 0.46 17.50b ± 5.85
24 5.0 11.07b ± 7.43 23.59b ± 1.87 46.86c ± 2.29 11.35a ± 2.42 13.09b ± 2.77 71.32b ± 2.73
44 4.5 0.68a ± 0.74 21.21b ± 1.33 47.49b ± 9.12 11.16a ± 1.69 23.78b ± 0.92 82.44b ± 8.13
Negative control 0 7.2 0.11 ± 0.05 0.13 ± 0.08 1.45 ± 0.29 0.14 ± 0.09 0.00 ± 0.00 1.83 ± 0.11
6 6.9 0.00a ± 0.00 0.00a ± 0.00 3.17a ± 0.31 0.95a ± 0.20 0.096a ± 0.16 4.22a ± 0.50
24 6.8 0.00a ± 0.00 0.00a ± 0.00 20.38a ± 2.67 4.68a ± 1.83 3.99a,b ± 0.59 29.06a ± 3.50
44 7.2 0.00a ± 0.00 0.00a ± 0.00 29.20a ± 0.82 6.21a ± 1.23 5.14a ± 0.19 40.55a ± 0.52
Starting concentrations of the test substrates were 1% (w/v). Mean values ± SD (n = 3). Different letters indicate significant differences (p ≤ 0.05)
for the same acid. Substrates were compared at three fermentation sampling times (6, 24 and 44 h).
551J o u rna l o f Func t i ona l F ood s 1 9 ( 2 0 1 5 ) 5 4 5 – 5 5 3
Acknowledgements
This study was financially supported by the European Seven
Framework programme (EU FP7), and is part of the AFTER
project (African Food Tradition Revisited by Research) under
contract no. 245-025. It was also supported by National Funds
from FCT – Fundação para a Ciência e a Tecnologia – through
project PEst-OE/EQB/LA0016/2013. We thank Safisis/Lesaffre for
providing the Lactobacillus casei (CNCM I-4592). B. Gullón is
grateful to the Portuguese Foundation for Science and Tech-
nology (Fundação para a Ciência e Tecnologia, FCT, Portugal) for
funding through the postdoctoral fellowship reference
SFRH/BPD/79941/2011.
R E F E R E N C E S
Akissoé, N. H., Sacca, C., Declemy, A. L., Bechoff, A., Anihouvi, V.
B., Dalodé, G., Pallet, D., Fliedel, G., Mestres, C., Hounhouigan,
J. D., & Tomlins, K. I. (2014). Cross-cultural acceptance of a
traditional yoghurt-like product made from fermented cereal.
Journal of the Science of Food and Agriculture, doi:10.1002/
jsfa.6892.
Belenguer, A., Duncan, S. H., Graham Calder, A., Holtrop, G.,
Louis, P., & Lobley, G. E. (2006). Two routes of metabolic cross-
feeding between Bifidobacterium adolescentis and butyrate
producing anaerobes from the human gut. Applied and
Environmental Microbiology, 72, 3593–3599.
Blandino, A., Al-Aseeri, M. E., Pandiella, S. S., Canterob, D., &
Webb, C. (2003). Cereal-based fermented foods and beverages.
Food Research International, 36, 527–543.
Conlon, M. A., & Bird, A. R. (2015). The impact of diet and
lifestyle on gut microbiota and human health. Nutrients, 7,
17–44.
Connolly, M. L., Tuohy, K. M., & Lovegrove, J. A. (2012). Wholegrain
oat-based cereals have prebiotic potential and low glycaemic
index. British Journal of Nutrition, 108, 2198–2206.
Costabile, A., Klinder, A., Fava, F., Napolitano, A., Fogliano, V.,
Leonard, C., Gibson, G. R., & Tuohy, K. M. (2008). Whole-grain
wheat breakfast cereal has a prebiotic effect on the human
gut microbiota: A double-blind, placebo-controlled, crossover
study. British Journal of Nutrition, 99, 110–120.
Davis, L. M. G., Martínez, I., Walter, J., Goin, C., & Hutkins, R. W.
(2011). Barcoded pyrosequencing reveals that consumption of
galactooligosaccharides results in a highly specific bifidogenic
response in humans. PLoS ONE, 6, e25200.
Delzenne, N. M., & Kok, N. (2001). Effects of fructan-type
prebiotics on lipid metabolism. American Journal of Clinical
Nutrition, 73, 456–458.
Dewulf, E. M., Cani, P. D., Claus, S. P., Fuentes, S., Puylaert, P. G.,
Neyrinck, A. M., Bindels, L. B., de Vos, W. M., Gibson, G. R.,
Thissen, J. P., & Delzenne, N. M. (2013). Insight into the
prebiotic concept: Lessons from an exploratory, double blind
intervention study with inulin. Gut, 62, 1112–1121.
Franz, C., Huch, M., Mathara, J. M., Abriouel, H., Benomar, N., Reid,
G., Galvez, A., & Holzapfel, W. H. (2014). African fermented
foods and probiotics. International Journal of Food Microbiology,
190, 84–96.
Gibson, G. R., & Roberfroid, M. B. (1995). Dietary modulation of
the human Colonie microbiota: Introducing the concept of
prebiotics. The Journal of Nutrition, 125, 1401–1412.
Gómez, B., Gullón, B., Remoroza, C., Schols, H. A., Parajó, J. C., &
Alonso, J. L. (2014). Purification, characterization, and prebiotic
properties of pectic oligosaccharides from orange peel
wastes. Journal of Agricultural and Food Chemistry, 62, 9769–
9782.
Gullón, B., Gullón, P., Sanz, Y., Alonso, J. L., & Parajó, J. C. (2011).
Prebiotic potential of a refined product containing pectic
oligosaccharides. LWT – Food Science and Technology, 44, 1687–
1696.
Gullón, B., Gullón, P., Tavaria, F., Pintado, M., Gomes, A. M.,
Alonso, J. L., & Parajó, J. C. (2014). Structural features and
assessment of prebiotic activity of refined
arabinoxylooligosaccharides from wheat bran. Journal of
Functional Foods, 6, 438–449.
Hartemink, R., Schoustra, S. E., & Rombouts, F. M. (1999).
Degradation of guar gum by intestinal bacteria. Bioscience and
Microflora, 18, 17–25.
Hernandez-Hernandez, O., Muthaiyan, A., Moreno, F. J., Montilla,
A., Sanz, M. L., & Ricke, S. C. (2012). Effect of prebiotic
carbohydrates on the growth and tolerance of Lactobacillus.
Food Microbiology, 30, 355–361.
Huebner, J., Wehling, R. L., & Hutkins, R. W. (2007). Functional
activity of commercial prebiotics. International Dairy Journal,
17, 770–775.
Kleessen, B., Hartmann, L., & Blaut, M. (2001). Oligofructose and
long-chain inulin: Influence on the gut microbial ecology of
rats associated with a human faecal flora. British Journal of
Nutrition, 86, 291–300.
Laparra, J. M., & Sanz, Y. (2010). Interactions of gut microbiota
with functional food components and nutraceuticals.
Pharmacological Research, 61, 219–225.
Maccaferri, S., Klinder, A., Cacciatore, S., Chitarrari, R., Honda, H.,
Luchinat, C., Bertini, I., Carnevali, P., Gibson, G. R., Brigidi, P., &
Costabile, A. (2012). In vitro fermentation of potential prebiotic
flours from natural sources: Impact on the human colonic
microbiota and metabolome. Molecular Nutrition & Food
Research, 56, 1342–1352.
Mathara, J. M., Schillinger, U., Kutima, P. M., Mbugua, S. K., &
Holzapfel, W. H. (2004). Isolation, identification and
characterization of the dominant microorganisms of kule
naoto: The Maasai traditional fermented milk in Kenya.
International Journal of Food of Microbiology, 94, 269–278.
Mills, D. J. S., Tuohy, K. M., Booth, J., Buck, M., Crabbe, M. J. C.,
Gibson, G. R., & Ames, J. M. (2008). Dietary glycated protein
modulates the colonic microbiota towards a more
detrimental composition in ulcerative colitis patients and
non-ulcerative colitis subjects. Journal of Applied Microbiology,
105, 706–714.
Miquel, S., Martín, R., Rossi, O., Bermúdez-Humarán, L. G., Chatel,
J. M., Sokol, H., Thomas, M., Wells, J. M., & Langella, P. (2013).
Faecalibacterium prausnitzii and human intestinal health.
Current Opinion in Microbiology, 16, 1–7.
Nago, M., Hounhouigan, J., Akissoé, N., Zanou, E., & Mestres, C.
(1998). Characterization of the Beninese traditional ogi, a
fermented maize slurry: Physicochemical and microbiological
aspects. International Journal of Food Science & Technology, 33,
307–315.
Pastell, H., Westermann, P., Meyer, A. S., Tuomainen, P., &
Tenkanen, M. (2009). In vitro fermentation of arabinoxylan-
derived carbohydrates by bifidobacteria and mixed fecal
microbiota. Journal of Agricultural and Food Chemistry, 57, 8598–
8606.
Reis, S. F., Gullón, B., Gullón, P., Ferreira, S., Maia, C. J., Alonso, J. L.,
Domingues, F. C., & Abu-Ghannam, N. (2014). Evaluation of
the prebiotic potential of arabinoxylans from brewer’s
spent grain. Applied Microbiology and Biotechnology, 98, 9365–
9373.
Rivas, S., Gullón, B., Gullón, P., Alonso, J. L., & Parajó, J. C. (2012).
Manufacture and properties of bifidogenic saccharides
derived from wood mannan. Journal of Agricultural and Food
Chemistry, 60, 4296–4305.
552 J o u rna l o f Func t i ona l F ood s 1 9 ( 2 0 1 5 ) 5 4 5 – 5 5 3
Rodrigues, D., Rocha-Santos, T. A. P., Pereira, C. I., Gomes, A. M.,
Malcata, F. X., & Freitas, A. C. (2011). The potential effect of
FOS and inulin upon probiotic bacterium performance in
curdled milk matrices. LWT – Food Science and Technology, 44,
100–108.
Rossi, M., Corradini, C., Amaretti, A., Nicolini, M., Pompei, A., &
Zanoni, S. (2005). Fermentation of fructooligosaccharides and
inulin by bifidobacteria: A comparative study of pure faecal
cultures. Applied and Environmental Microbiology, 71, 6150–6158.
Russell, W. R., Hoyles, L., Flint, H. J., & Dumas, M.-E. (2013).
Colonic bacterial metabolites and human health. Current
Opinion in Microbiology, 16, 246–254.
Sacca, C., Adinsi, L., Anihouvi, V., Akissoe, N., Dalode, G., Mestres,
C., Jacobs, A., Dlamini, N., Pallet, D., & Hounhouigan, D. J.
(2012). Production, consumption, and quality attributes of
Akpan – a yoghurt-like cereal product from West Africa. Food
Chain, 2(2), doi:10.3362/2046-1887.2012.018.
Salazar, N., Ruas-Madiedo, P., Kolida, S., Collins, M., Rastall, R.,
Gibson, G., & de los Reyes-Gavilán, C. G. (2009).
Exoplysaccharides produced by Bifidobacterium longum IPLA
E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify
the composition and metabolic activity of human microbiota
in pH-controlled batch cultures. International Journal of Food
Microbiology, 135, 260–267.
Sarbini, S. R., Kolida, S., Naeye, T., Einerhand, A., Brison, Y.,
Remaud-Simeon, M., Monsan, P., Gibson, G. R., & Rastall, R. A.
(2011). In vitro fermentation of linear and -1,2-branched
dextrans by the human fecal microbiota. Applied and
Environmental Microbiology, 77, 5307–5315.
Schiffrin, E. J., & Blum, S. (2002). Interactions between the
microbiota and the intestinal mucosa. European Journal of
Clinical Nutrition, 56, S60–S64.
Scott, K. P., Martin, J. C., Duncan, S. H., & Flint, H. J. (2014).
Prebiotic stimulation of human colonic butyrate-producing
bacteria and bifidobacteria, in vitro. FEMS Microbiology and
Ecology, 87, 30–40.
Tadayoni, M., Sheikh-Zeinoddin, M., & Soleimanian-Zad, S.
(2015). Isolation of bioactive polysaccharide from acorn and
evaluation of its functional properties. International Journal of
Biological Macromolecules, 72, 179–184.
Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A., &
Jenkins, D. J. A. (2006). Colonic health: Fermentation and short
chain fatty acids. Journal of Clinical Gastroenterology, 40, 235–
243.
553J o u rna l o f Func t i ona l F ood s 1 9 ( 2 0 1 5 ) 5 4 5 – 5 5 3
